Dietary Supplement Regulation

Dietary supplement regulation is the weak U.S. oversight system described in Why is there a supplement craze if they don’t even work?. The episode argues that supplements sit awkwardly between food and drugs: they look like health products, but most do not need drug-style proof of effectiveness before sale.

The concept matters because it connects business design to legal design. Frank Cantone can help a brand assemble gummies, capsules, powders, flavors, ingredients, and acceptable label language, while the Dietary Supplement Health and Education Act lets many products make broad wellness claims through Supplement Structure Function Claims rather than evidence-backed treatment claims.

Key Claims

• Supplements can be marketed as health-supporting products without proving they make healthy people healthier.
• [[FoodAndDrugAdministration|FDA]] oversight is narrower than many consumers may infer from health-oriented packaging.
• Claim wording matters: “supports” and “promotes” suggest benefit without becoming disease-treatment claims.
• Safety review is also limited; many products do not require ordinary premarket safety proof.
• Enforcement can be slow and divided across agencies, as shown by the Prevagen case involving FDA safety concerns and later [[FederalTradeCommission|FTC]] advertising action.
• Consumer protection therefore depends partly on Supplement Label Accuracy, Third-Party Supplement Testing, and skepticism about Supplement Placebo Effect.

Connections

• Dietary Supplement Health and Education Act - law that anchors the source’s regulatory story.
• Supplement Structure Function Claims - label language made possible by the regulatory system.
• Food and Drug Administration and Federal Trade Commission - agencies with different roles.
• GRAS Self-Certification - food-law pathway that can interact with supplement sales.
• Medical AI Marketing Risk and Online Healthcare Regulatory Boundary - adjacent health-trust and regulatory-boundary pages.